Despite federal legislation, shortages of drugs used in acute care settings remain persistent and prolonged. | AHRQ Patient Safety Network

Despite federal legislation, shortages of drugs used in acute care settings remain persistent and prolonged. | AHRQ Patient Safety Network

• Study
 
• Published May 2016

Despite federal legislation, shortages of drugs used in acute care settings remain persistent and prolonged.

Chen SI, Fox ER, Hall MK, et al. Health Aff (Millwood). 2016;35:798-804.

Drug shortages have been a persistent problem for several years and have been shown to affect patient safety. The Food and Drug Administration Safety and Innovation Act of 2012 was intended to address these shortages. This analysis found that while shortages have decreased since the act was passed, problems with drug supply for acute care facilities remain.

PubMed citationAvailable atRelated news article

Related Resources

JOURNAL ARTICLE › COMMENTARY

Regulating patient safety: The Patient Protection and Affordable Care Act.

Furrow BR. Univ PA Law Rev. 2011;159:1727-1775.

JOURNAL ARTICLE › COMMENTARY

Meaningful use and certification of health information technology: what about safety?

Hoffman S, Podgurski A. J Law Med Ethics. 2011;39(suppl 1):77-80.

NEWSPAPER/MAGAZINE ARTICLE

Approved: no new National Patient Safety Goals, only minor revisions for 2011.

Jt Comm Perspect. August 2010;30:6-7.

WEB RESOURCE › MULTI-USE WEBSITE

Medical Liability Reform & Patient Safety Initiative.

Rockville, MD: Agency for Healthcare Research and Quality.

JOURNAL ARTICLE › COMMENTARY

Market-based control mechanisms for patient safety.

Coiera E, Braithwaite J. Qual Saf Health Care 2009;18:99-103.

View More